Showing results (621-630 of 744) with videos related to
Sort By:
Pageof 75
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic MelanomaDirk Schadendorf, F Stephen Hodi, Caroline Robert, et al.BJU International|April 16, 2014
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk featureFarzana A Faisal, Debasish Sundi, Phillip M Pierorazio, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|June 5, 2019
Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsiesNicole Morse, Tamara Jamaspishvili, David Simon, et al.BJU International|November 15, 2011
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsiesBruce J Trock, Michelle J Brotzman, Leslie A Mangold, et al.European Urology|October 2, 2012
Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient careOsamu Ukimura, Jonathan A Coleman, Alex de la Taille, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2011
ERG gene rearrangements are common in prostatic small cell carcinomasTamara L Lotan, Nilesh S Gupta, Wenle Wang, et al.The American Journal of Surgical Pathology|May 18, 2023
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical UtilityJoshua I Warrick, Hikmat Al-Ahmadie, David M Berman, et al.Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.JAMA|November 16, 2006
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks, Norman A Mazer, Elahe Mostaghel, et al.Human Pathology|December 3, 2014
Utility of uroplakin II expression as a marker of urothelial carcinomaWei Tian, Gunes Guner, Hiroshi Miyamoto, et al.Pageof 75